Anixa Biosciences Inc — Director's Dealing 2017

Jan 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-01-03

Reporting Person: Baskies Arnold M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Employee Stock Option (Right to Buy)	$5.3	A	12000	Acquired	2027-01-03	Common Stock (12000)	Direct

Footnotes

F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.

F2: The options vest and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017.